Dirk Bastian

Dr. Dirk Bastian


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2011 in EP Europace
Verified
Journal Article
Open access
PDF file
MAMarco Alings
Marco Alings
EVElisa Vireca
Elisa Vireca
DBDirk Bastian
Dirk Bastian
AWAlexander Jacques Wardeh
Alexander Jacques Wardeh
CNC. Nimeth
C. Nimeth
FIfor the AUTOMATICITY Study Investigators
for the AUTOMATICITY Study Investigators
Follow-up of the ever-increasing numbers of patients with implantable cardiac devices places a heavy burden on clinical departments. Device automaticity may alleviate the follow-up burden by minimizing the time for physician involvement. The aim of the prospective, multicentre AUTOMATICITY registry was to examine the performance of a subset of programmed automatic algorithms during patient follow-up and their acceptance by implanting physicians. The clinical use of automatic algorithms from the InsigniaTM pacemakers (PM; Boston Scientific, St Paul, MN, USA) was evaluated: atrial and ventricular AutoSense (sensitivity adjustment), ventricular Automatic Capture (threshold verification and output setting), AutoLifeStyleTM (sensor settings adjustment). The objective of the study was to assess the reprogramming rates within 12 months of implant, the reasons for reprogramming and relationship to adverse events. A total of 960 patients were enrolled in the study. The proportion of patients free from any algorithm reprogramming at 12 months was 86.1%. A total of 2736 algorithms were activated at enrolment, with 156 (5.7%) being reprogrammed in 115 patients at 12 months for any reason. Forty-nine reprogrammings (1.8%) were unintentional or related to changes in device settings such that the algorithm was no longer available, 33 (1.2%) were due to suspected sensing issues, and 22 (0.8%) were assumed related to the algorithm. The individual 12-month reprogramming-free rates were: ventricular AutoSense 94.3%, Atrial AutoSense 93.3%, AutoLifeStyleTM 93.9%, and Automatic Capture 95.9%. The results of the AUTOMATICITY registry show that automatic measurement of key settings and automatic adjustment to optimal programming is feasible and safe. The simplicity of PM follow-up and avoidance of frequent reprogramming may contribute to a more effective use of hospital time and resources.

13 June 2018 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
PDF file
DBDirk Bastian
Dirk Bastian
IEIftikhar O. Ebrahim
Iftikhar O. Ebrahim
JCJu-Yi Chen
Ju-Yi Chen
MCMien-Cheng Chen
Mien-Cheng Chen
DHDejia Huang
Dejia Huang
OIon behalf of the PANORAMA 2 investigators
on behalf of the PANORAMA 2 investigators

14 December 2021 in Sensors
Verified
Journal Article
Open access
PDF file
ANAlexander Niedermeier
Alexander Niedermeier
Laura Vitali-SerdozLaura Vitali-Serdoz
Laura Vitali-Serdoz
Theodor FischleinTheodor Fischlein
Theodor Fischlein
WKWolfgang Kirste
Wolfgang Kirste
VBVeronica Buia
Veronica Buia
DBDirk Bastian
Dirk Bastian
Background: ICDs and pacemakers for cardiac resynchronization therapy (CRT) are complex devices with different sensors and automatic algorithms implanted in patients with advanced cardiac diseases. Data on the perioperative management and outcome of CRT carriers undergoing surgery unrelated to the device are scarce. Methods: Data from 198 CRT device carriers (100 with active rate responsive sensor) were evaluated regarding perioperative adverse (device-related) events (A(D)E) and lead parameter changes. Results: Thirty-nine adverse observations were documented in 180 patients during preoperative interrogation, which were most often related to the left-ventricular lead and requiring intervention/reprogramming in 22 cases (12%). Anesthesia-related events occurred in 69 patients. There was no ADE for non-cardiac surgery and in pacemaker-dependent patients not programmed to an asynchronous pacing mode. Post-operative device interrogation showed significant lead parameter changes in 64/179 patients (36%) requiring reprogramming in 29 cases (16%). Conclusion: The left-ventricular pacing lead represents the most vulnerable system component. Comprehensive pre and post-interventional device interrogation is mandatory to ensure proper system function. The type of ICD function suspension has no impact on each patient’s outcome. Precautionary activity sensor deactivation is not required for non-cardiac interventions. Routine prophylactic device reprogramming to asynchronous pacing appears inessential. Most of the CRT pacemakers do not require surgery-related reprogramming.

4 March 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DBDirk Bastian
Dirk Bastian
CGCaterina Gregorio
Caterina Gregorio
VBVeronica Buia
Veronica Buia
JWJanusch Walaschek
Janusch Walaschek
HRHarald Rittger
Harald Rittger
Laura Vitali-SerdozLaura Vitali-Serdoz
Laura Vitali-Serdoz
Pace mapping and visual comparison of the local pacing response with the intrinsic QRS morphology form the mainstay of His bundle pacing (HBP). We evaluated the performance of a surface lead morphology match algorithm for automated classification of the pacing response in patients with narrow intrinsic QRS undergoing electroanatomic mapping (EAM)-guided HBP. HBP was attempted in 43 patients. In 28 cases with narrow QRS, the EnSite AutoMap Module was used for automated assessment of the QRS morphology resulting from pace mapping in the His cloud area with either a diagnostic catheter or the His lead. An intrinsic morphology match score (IMS) was calculated for 1.546 QRS complexes and assessed regarding its accuracy and performance in classifying the individual pacing response as either selective HBP (S-HBP), nonselective HBP (NS-HBP) or right ventricular stimulation. Automated morphology comparison of 354 intrinsic beats with the individual reference determined a test accuracy of 99% (95% CI 98.96–99.04) and a precision of 97.99–99.5%. For His-lead stimulation, an IMS ≥ 89% identified S-HBP with a sensitivity, specificity and positive predictive value of 1.00 (0.99, 1.00) and a negative predictive value of 0.99 (0.98, 1.00). An IMS between 78 and < 89% indicated NS-HBP with a sensitivity and specificity of 1.00 (0.99, 1.00) and 0.99 (0.98, 1.00), respectively. IMS represents a new automated measure for standardized individual morphology classification in patients with normal QRS undergoing EAM-guided HBP.Clinical trial registration: NCT04416958.

2 May 2020 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
PDF file
DBDirk Bastian
Dirk Bastian
VBVeronica Buia
Veronica Buia
JWJanusch Walaschek
Janusch Walaschek
EQEugenio De Quattro
Eugenio De Quattro
HRHarald Rittger
Harald Rittger
Laura Vitali-SerdozLaura Vitali-Serdoz
Laura Vitali-Serdoz

1 May 2018 in EP Europace
Verified
Journal Article
Open access
PDF file
DBDirk Bastian
Dirk Bastian
JSJohannes Schwab
Johannes Schwab
KSKarl-Theodor Steurer
Karl-Theodor Steurer
ABAndrea Brinker-Paschke
Andrea Brinker-Paschke
ABArno Boessenecker
Arno Boessenecker
KGKonrad Göhl
Konrad Göhl
Oesophagogastroduodenoscopy (OGD) after catheter ablation (CA) of atrial fibrillation (AF) revealed a high rate of procedure related oesophageal lesions. We hypothesized that magnetically guided CA with careful radiofrequency energy titration at the posterior left atrial (LA) wall limits the incidence of oesophageal tissue damage. As a part of the prospective “Remote MAGNetic catheter Ablation for Atrial Fibrillation” (MAGNA-AF) registry, 251 out of 266 consecutive patients underwent OGD after magnetically guided single-CA for AF. All detected pathologies were analysed. Simultaneous pacing and ablation from the tip of the magnetically guided catheter was found to be a safe and feasible method for energy titration. Post-interventional OGD documented midoesophageal tissue damage in four (1.6%) patients. Although a thermal origin of these injuries must be discussed, none of them was located at the anterior oesophageal wall. Risk factors for midoesophageal lesions were female gender and concomitant acetylsalicylic acid (ASA) treatment. Mechanical lesions in 16 patients were attributed to periprocedural transoesophageal echocardiography (TOE). There was no atrio-oesophageal fistula (AOF). Five hundred and one incidental pathologies were found endoscopically, most frequent axial oesophageal herniation (71%), oesophagitis (22%), and gastritis (57%). Magnetically guided CA for AF with careful energy titration at the posterior LA wall and no oesophageal temperature monitoring is not associated with an increased incidence of oesophageal thermal injury. The routine use of periprocedural TOE may cause a low rate of mechanical oesophageal lesions but reliably prevents major complications like transient ischaemic attack, stroke, or cardiac tamponade. An observed high prevalence of upper digestive system inflammation (63%) may further support the recommendation for a routine post-interventional treatment with a proton-pump-inhibitor.